APVO vs SPCE · $9.9M cap vs rev $361.0K
Aptevo Therapeutics Inc (APVO) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
Aptevo Therapeutics Inc (APVO) is a biotechnology company listed on US.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
APVO does not have a complete income-statement cache yet.
Latest reported SPCE revenue for 2026-06-30 was $361.0K. Net income was -$120.6M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. SPCE currently screens at market cap $388.0M.
APVO currently screens at market cap $9.9M. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the APVO and SPCE stock pages for the full models.
Not investment advice.